🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Very High Risk Acute Lymphoblastic Leukemia

Orphan Indications for CD19 Redirected Autologous T Cells NCT04276870Phase 21 site📍 Philadelphia Stephan Grupp MD PhD · Tests: Murine CART19 Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation NCT06247501Phase 21 site📍 Seoul Seoul National University Hospital · Tests: SNUH-CD19-CAR-T A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL NCT05748171Phase 265 sites📍 Vienna📍 Brussels📍 Ghent Pfizer · Tests: Inotuzumab ozogamicin, ALLR3 Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea NCT06257394Phase 210 sites📍 Daegu📍 Daejeon📍 Hwasun Hyoung Jin Kang · Tests: Dasatinib(Sprycel) arm, Non-Dasatinib(Sprycel) arm
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy